Published

Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JAMA Network Open
Date: 2026-09-29
Source: Crossref
DOI: 10.1001/jamanetworkopen.2026.36756
PubMed: 42809289

Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed: 2026-09-30 01:20:19 UTC
Metadata last checked: 2026-10-06 01:20:28 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Simonsson Otto Bradley Melissa Black Joshua C.Rockhill Karilynn M.Monte Andrew A.Hendricks Peter S.

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

psilocybin Observational Study Observational Study

Citation graph

8 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

10.1038/s41591-023-02565-4 10.1038/s41591-023-02705-w 10.1111/add.70260 10.1001/jamahealthforum.2024.3630 10.1001/jamapsychiatry.2022.4101 10.2196/86059 10.1016/j.jad.2024.08.091 10.1111/add.15448

Related papers

No close related records were found yet.